anti-bcl-2 ribozyme (Columbia University)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug Nameanti-bcl-2 ribozyme (Columbia University)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > RibozymeSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide

Mechanisms of ActionApoptosis regulator Bcl-2 inhibitors

TargetsApoptosis regulator Bcl-2

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesColumbia University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesColumbia University

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A